PATENT CLAIM ANALYSIS

Application Number: 16186769
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "252010"]

Abstract:
Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof: Also disclosed herein are uses of a compound disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of a composition in the potential treatment or prevention of an IDO-associated disease or disorder.

Claim (Index 3):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein:\n n is 1; p is 1; each A group is \u2014CH\u2550; or alternatively, one A group is \u2014N\u2550 and the three other A groups are each \u2014CH\u2550; or alternatively, two A groups are each \u2014N\u2550 and the two other A groups are each \u2014CH\u2550; and M is selected from \u2014O\u2014, \u2014CH 2 \u2014, \u2014CHF, \u2014CF 2 \u2014 and

Metadata:
- Claim Count in Document: 34.0
- Percentile: 98.0
- Lexical Diversity: 2.08571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16061597', '13780510', '11641284', '13501633', '11430441']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8199349007094958
- 35 USC 102 Novelty (BERT): 0.5572952138970448
- Combined Prediction Score: 0.7936709320282507
- Mean Citation Score: 392.197194
- Max Citation Score: 435.63135
- Similarity Product: 335.3770074016839

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test